Institutional investors purchased a net $2.7 million shares of IMMU during the quarter ended March 2014, and now own 38.78% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TFS CAPITAL LLC Bought 163.4 Thousand shares of Immunomedics Inc
STATE TEACHERS RETIREMENT SYSTEM... Sold 27.3 Thousand shares of Immunomedics Inc